Finance And Related Services Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Completion of Non-exclusive Am Discount Agreements According to Section 130a (8) Sgb V by Means of a So-called Open-house Model for the Ws Aripiprazole for the Parenteral Application (atc Code According to Who: N05ax12)

Completion of Non-exclusive Discount Agreements As Part of a So-called Open House Model for Various X-ray Contrast Agents (atc Code According to Who: V08)

Completion of Non-exclusive Drug Discounts According to § 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Dasatinib (atc Code According to Who: L01ea02)

Conclusion of a Non-Exclusive Framework Contract for Structural Inspections in the Open House Procedure of the Southwest Branch

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Openhouse Procedure Blood Glucose Test Strips

Openhouse Process Blood Sugar Test Strips

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Ingredient Everolimus (Atc L01eg02)

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Ingredient Etanercept (Atc Code According to Who: L04ab01)